ANO1 and metastatic malignant neoplasm in the lymph nodes: Stratified analysis in different clinico-pathological characteristics also indicated a poorer prognosis of ANO1-expressed patients, especially which were female (P = 0.0165), male (P = 0.0212), over 60 years old (P = 0.0008), and for those with tumors of middle location (P = 0.0066), moderate/poor differentiation (G2/3, P = 0.0047 and 0.0256, respectively), advanced stages (pT3 and stages IIB/III, P = 0.0035, 0.0091 and 0.0337, respectively), as well as without lymph node metastasis and with N2 (P = 0.0389 and 0.0096) (Table 2, Figure 2).